Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
Omics International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums so far in the field.
Movement disorders are a group of conditions characterized by alteration in normal motility, posture or tone, alone or in combination. The movement abnormalities may be seen with lesions of the cerebral hemispheres, cerebellum, and brainstem or in metabolic disorders, the most common site is the extrapyramidal system. Movement disorder manifestations are characterized as either hyperkinetic or hypokinetic. Hyperkinetic movement disorders include tremor, chorea, ballismus, athetosis, myoclonus,tics, and dyskinesias. All movement disorders are worsened with stress, fatigue, anxiety or concomitant illness.
OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that ConferenceSeries hosts over 700 edge peer reviewed Open Access Journals and organizes over more than 1000 Global Events annually. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 75000+ eminent personalities that ensure a quality and quick review process checker.
Parkinson's disease is a progressive, degenerative neurological movement disorder that affects approximately 6.3 million people worldwide. Although it typically develops after the age of 65, about 15% of people with the condition develop "young-onset" Parkinson's disease before reaching age 50. 500 - 600 male new-borns are diagnosed with muscular dystrophy each year in the US, Duchenne and Becker types. The Parkinson's Disease Foundation estimates that that 60,000 new cases of Parkinson's disease are diagnosed each year, adding to the seven to 10 people who have the disease worldwide.
The US will have the largest PD therapeutics market share of 44% by 2022, expanding from 32% in 2012. This will be followed by Japan, Brazil and Germany, with respective shares of 13%, 11% and 10%. The Parkinson Disease market was worth USD 3.6 billion in 2012 and is expected to reach USD 5.3 billion in 2022, growing at a CAGR of 4% from 2012 to 2022.
Movement disorders are a group of conditions characterized by alteration in normal motility, posture and tone alone or can be in combination. Changes caused by motor paralysis severe sensory loss, painful syndromes or skeletal deformities etc. are not included in these disorders.Though movement abnormalities may be seen with lesions of the cerebral hemispheres, cerebellum, and brainstem or in metabolic disorders, the most common site is the extra pyramidal system. This is aphylogenetically older motor system and is responsible for regulation of tone, automatic movements and posture.
The basal ganglia cannot produce fine voluntary movement in man, which is a function of the pyramidal system. The extra pyramidal system sets the background for efficient functioning of the pyramidal system. Movement disorder manifestations are characterized as either hyperkinetic or hypokinetic. Hyperkinetic movement disorders include tremor, chorea, ballismus, athetosis, myoclonus, tics and dyskinesias.
All movement disorders are worsened with stress, fatigue, anxiety or concomitant illness. Parkinsonism is a hypokinetic movement disorder, with overall paucity of Movement with the exception of tremor. Dystonia is also a combination of hypokinesis and hyperkinesis, with the dominant picture of increased tone caused by agonist and antagonist co-contraction with rare dystonic tremor.
Tremor is the most common movement disorder. These are stereotyped, repetitive, rapid coordinated movements. Dystonia is characterized by sustained muscle contractions resulting in abnormal movement or posture. Athetosis is a relatively uncommon movement disorder.
List of Best International Conferences
2nd Parkinson’s Disease and Movement Disorders Conference November 28-30, 2016 Chicago, USA
2nd Brain Disorders Conference October 27-29, 2016 Chicago, USA
5th Neurology Conference, March 14-16, 2016 London, UK.
2nd Neurological Disorders and Stroke Conference April 28-30, 2016 Dubai, UAE
Autism Conference, May 5-6, 2016 Chicago, USA
6th Neurological Conference May 19-21, 2016 San Antonio, USA
Eating Disorders Congress August 15-17, 2016 Portland, Oregon
4th Vascular Dementia Conference June 30-July 2, 2016 Valencia, Spain
5th Alzheimer’s Disease and Dementia Conference September 29-Oct 1, 2016 London, UK
2nd Sleep Disorders Conference November 28- 30, 2016 Chicago, USA
2nd Epilepsy Conference October 24-26, 2016 Rome, Italy
17th International Congress of Parkinson’s Disease and Movement Disorders.
10th International Congress on Non-Motor Dysfunctions in Parkinson’s disease and Related Disorders
16th International Congress of Parkinson’s disease and Movement Disorders.
19th international congress of Parkinson’s disease and movement disorders
6th Fred J. Epstein International Symposium on New Horizons in Pediatric Neurology.
List of Related Societies:
The International Parkinson and Movement Disorder Society.
The Movement Disorder Society.
American Society of Stereotactic and Functional Neurosurgery.
Austrian Parkinson's Disease Society
Danish Movement Disorder Society
National Parkinson Foundation
American Parkinson Disease Association (APDA)
Parkinson’s disease Foundation
Movement Disorder Society of Australia
Movement Disorder Society of Japan
Moroccan Neurological Society Movement Disorders Group
Italian Society for the Study of Parkinson Disease, Extrapyramidal Diseases and Dementia
Ecuador Movement Disorders Group
List of Related Companies:
Biogen Idec
Dainippon Sumitomo Pharma
BioSante Pharmaceuticals
GlaxoSmithKline (GSK)
Boehringer Ingelheim
The Johns Hopkins Movement Disorders Center
UW Hospital and Clinics
Movement Disorders Diagnostic Technologies
Beth Israel Deaconess Medical Center
Hocoma
This page will be updated regularly.
This page was last updated on November 21, 2024
